Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 8 September 2005. doi:10.1136/ard.2005.039032
Annals of the Rheumatic Diseases 2006;65:501-507
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism.

EXTENDED REPORT

Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography

N J Peake1, H E Foster1, K Khawaja2, T E Cawston1, A D Rowan1

1 Musculoskeletal Research Group, School of Clinical Medical Sciences, University of Newcastle-upon-Tyne, UK
2 Department of Paediatrics, Newcastle Hospitals NHS Trust, Newcastle-upon-Tyne, UK

Correspondence to:
Dr A D Rowan
Musculoskeletal Research Group, School of Clinical Medical Sciences, Medical School Cookson Building, University of Newcastle upon Tyne, NE2 4HH, UK; a.d.rowan{at}ncl.ac.uk

Objective: To measure gelatinase activities in paired synovial fluid (SF) and serum of patients with juvenile idiopathic arthritis (JIA), and to assess how these activities relate to clinical and laboratory measures of disease activity.

Methods: A quantitative protein substrate zymography method was adapted and validated for use with serum and SF. Bands of activity were measured by densitometry and correlated with standard laboratory indicators of inflammation: erythrocyte sedimentation rate and platelet count.

Results: Gelatinase activity was found consistently in patients with JIA, with reproducible, quantified bands of activity corresponding to pro-matrix metalloproteinase-9 (pro-MMP-9), including the neutrophil associated lipocalin complex, and pro- and active forms of MMP-2. Both active MMP-2 and pro-MMP-9 were higher in JIA serum than in controls, though no differences were seen between patients grouped according to age, disease duration, or JIA subtype. However, SF MMP-9 correlated significantly with the laboratory indicators of inflammation, as did the relative level of active MMP-2.

Conclusions: Both MMP-2 and MMP-9 gelatinolytic activities are raised during active JIA and associated with inflammatory activity regardless of age and disease duration, supporting a role for MMPs in the breakdown of joint components from early in disease. These MMPs may be specific markers of active joint destruction linked to inflammatory JIA, MMP-9 as a product of infiltrating cells, and the activation of MMP-2 produced within the joint.

Abbreviations: DMARD, disease modifying antirheumatic drug; ESR, erythrocyte sedimentation rate; FRH, Freeman Hospital; ILAR, International League Against Rheumatism; JIA, juvenile idiopathic arthritis; MMP, matrix metalloproteinase; NSAID, non-steroidal anti-inflammatory drug; PLT, platelet count; SDS, sodium dodecyl sulphate; SF, synovial fluid

Keywords: gelatinase; matrix metalloproteinases; zymogram; juvenile idiopathic arthritis; cartilage


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs